The purpose of this study is to evaluate the long-term efficacy and safety of entecavir 0.5
mg/d + adefovir 10 mg/d for treatment experienced chronic hepatitis B patients.
Phase:
Phase 4
Details
Lead Sponsor:
Nanfang Hospital of Southern Medical University
Collaborator:
Major Science and Technology Special Project of China 12th Five-year